GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The neuroprotective activity of a novel N‐acylprolyl‐containing dipeptide analog of the nootropic 2‐oxo‐1‐pyrrolidine acetamide (Piracetam) designated as GVS‐111 (DVD‐111/Noopept) was tested in two in vitro models of neuronal degeneration mediated by oxidative stress: normal human cortical neurons treated with H 2 O 2, and Down's syndrome (DS) cortical neurons. Incubation of normal cortical neurons with 50 μM H 2 O 2 for 1 h resulted in morphological and structural changes consistent with neuronal apoptosis and in the degeneration of more than 60% of the neurons present in the culture. GVS‐111 significantly increased neuronal survival after H 2 O 2‐treatment displaying a dose‐dependent neuroprotective activity from 10 nM to 100 μM, and an IC 50 value of 1.21±0.07 μM. GVS‐111 inhibited the accumulation of intracellular free radicals and lipid peroxidation damage in neurons treated with H 2 O 2 or FeSO 4, suggesting an antioxidant mechanism of action. GVS‐111 exhibited significantly higher neuroprotection compared to the standard cognition enhancer Piracetam, or to the antioxidants Vitamin E, propyl gallate and N‐tert‐butyl‐2‐sulpho‐phenylnitrone (s‐PBN). In DS cortical cultures, chronic treatment with GVS‐111 significantly reduced the appearance of degenerative changes and enhanced neuronal survival. The results suggest that the neuroprotective effect of GVS‐111 against oxidative damage and its potential nootropic activity may present a valuable therapeutic combination for the treatment of mental retardation and chronic neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., & Green, D. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1545 · Cited by 2,824 · cited 2×
“For some experiments, lipid peroxidation was induced by treatment of cortical cultures with 10 mM FeSO4 as previously described (Goodman et al., 1996; Goodman and Mattson, 1996).”
BackgroundMethodHydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · cited 2×
“induces neurotoxicity through different molecular pathways (Behl et al., 1994; Yankner, 1996; Grace and Busciglio, 2003).”
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741 · cited 15×
“Degenerating DS neurons show increased intracellular levels of ROS, membrane blebbing, chromatin condensation and positive TUNEL staining consistent with apoptotic cell death (Busciglio and Yankner, 1995).”
BackgroundMethodResultInfluentialSelf-citationDown's syndrome: Is there a decreased population of neurons?
Ross, M. H., Galaburda, A. M., & Kemper, T. L. (1984) · Neurology · doi:10.1212/wnl.34.7.909 · Cited by 191
Grace, E. A., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00493.2003 · Cited by 113 · cited 1×
“Interestingly, GVS-111 exhibited limited neuroprotection after amyloid (A ) treatment (data not shown), supporting the notion that A induces neurotoxicity through different molecular pathways (Behl et al., 1994; Yankner, 1996; Grace and Busciglio, 2003).”
BackgroundSelf-citation
Cited by
Deshpande, A., Mina, E., Glabe, C., & Busciglio, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 494
Self-citationDeshpande, A., Kawai, H., Metherate, R., Glabe, C. G., & Busciglio, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5980-08.2009 · Cited by 232
Self-citationMouse models of Down syndrome as a tool to unravel the causes of mental disabilities
Rueda, N., Flórez, J., & Martínez-Cué, C. (2012) · Neural Plasticity · doi:10.1155/2012/584071 · Cited by 171
Yeo, M., Berglund, K., Hanna, M., Guo, J. U., Kittur, J., Torres, M. D., Abramowitz, J., Busciglio, J., Gao, Y., Birnbaumer, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300959110 · Cited by 124
Self-citationGarcia, O., Torres, M., Helguera, P., Coskun, P., & Busciglio, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014200 · Cited by 122
Self-citation
Metadata
- Authors
- Pelsman, A., Hoyo‐Vadillo, C., Gudasheva, T. A., Seredenin, S. B., Ostrovskaya, R. U., & Busciglio, J.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2003-04-11
- Volume
- 21
- Issue
- 3
- Pages
- 117-124
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W2024491864
- Cited by
- 65
- References
- 5
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. https://app.cochat.ai/papers/10.1016/s0736-5748(03)00031-5
- The paper
- Pelsman, A., Hoyo‐Vadillo, C., Gudasheva, T. A., Seredenin, S. B., Ostrovskaya, R. U., & Busciglio, J. (2003). GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. International Journal of Developmental Neuroscience. https://doi.org/10.1016/s0736-5748(03)00031-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.